STAT China: Lineup for Hong Kong IPO grows, and a conversation with Junshi’s Li Ning
A version of this digest first appeared in the weekly STAT China newsletter. To receive future editions, sign up here.
Happy Tuesday and welcome back to STAT China. The CEO of Junshi Biosciences joins us for our latest “newsmaker” interview, and we’ve got lots of news from the IPO and vaccine front.
